This week in TalkOnDiabetes.net - and thank you to you all!
Hello, Friends,
First, I would like to thank over 300,000 of you for visiting us and
sending us letters. Your support since the 5-month republication of
TalkOnDiabetes.net has been outstanding, and I am personally touched
and honored that so many people who have been afflicted with this
disease would choose TalkOnDiabetes.net as one of their medical
resource sites. I thank you from the bottom of my heart.
Here are the latest headlines from TalkOnDiabetes.net
> In the News
>>Special News from TalkOnDiabetes.net:
Researchers Make Cloning Breakthrough
Researchers in South Korea have become the first to successfully
clone a human embryo, and then cull from it master stem cells that
many doctors consider key to one day creating customized cures for
diabetes, Parkinson’s and other diseases Read More
Do you have a diabetic child? Parents, please visit our Care for Kids
area
Come and read a message of encourage and support from
TalkOnDiabetes.net
TalkOnDiabetes.net is proud to anounce that we now have a listing of
over 20,000 clinical trial listings. Please come and take a look.
>In the Legal area
>>Are you aware of your rights as a disabled person? If you have any
documents to prove that you are, in fact, diabetic, you have RIGHTS!
You can read more about them here, depending on your location.
USA: A Guide to Disability Rights Laws
Canada: Ontario with Disabilities Act
Australia: Disability Rights
UK: Disabilities Discrimation Act
>In the About Diabetes
>>FREE SUPPLIES HERE - Now that we’ve got your attention, why not
check them out! Click here.
>Summer’s coming. Support our cause and get a powerful T-Shirt. Click
here.
JOIN OUR MAILING LIST, AND GET THE NEWS AND HEALTHY INFO FIRST FROM
ALL OVER THE WORLD!!
All of this and so much more, here at TalkOnDiabetes.net
www.TalkOnDiabetes.net. Think about it. Learn about it. Talk about
it.
Regards,
Ashley
TalkOnDiabetes staff
This is a weekly notice of content issued from TalkOnDiabetes.net. We
strongly advise all recipients to read our disclaimer. If you wish
not to receive this notice, please reply with the subject "Remove
from list".